The first 60 days: Incidental gallbladder cancer (found after cholecystectomy)
Incidental gallbladder cancer is cancer the pathologist finds in a gallbladder removed for gallstones or inflammation, when nobody suspected it. It is the commonest way this cancer is found early enough to cure. Whether a second operation is needed depends on how deep the tumour went: none for the earliest layers, a radical operation at a specialist centre for T1b or deeper. Below, week by week, is what OnCo's record of Incidental gallbladder cancer (found after cholecystectomy) says about the first two months: the order is typical, the timing is yours to ask about. Sections appear only where the record has something to say. Orientation, not medical advice.
What happens now
Staging tests establish exactly what and where the cancer is. Everything else follows from the answers.
Ask which of these were tested and what the results were; see the report reader for what each value means.
These specialties appear in the standard of care for this cancer. In most centres they meet weekly as a tumour board to agree each plan; you can ask when yours was discussed and what was decided.
- RadiologistNamed in the standard of care for: T1b, T2 or T3, no metastases.
- SurgeonNamed in the standard of care for: Tis or T1a with a clear cystic duct margin, T1b, T2 or T3, no metastases.
- Medical oncologistNamed in the standard of care for: T1b, T2 or T3, no metastases, Residual disease found on interval imaging or at re-operation.
A second opinion from a centre that treats many similar cases is normal, not rude; the standard of care tells you what to compare it against.
Each row is a setting from the standard of care, in the order it usually arises. Not all will apply to you; your stage and biomarkers decide which do. The guideline grade, where recorded, says how strong the evidence is.
No further surgery; the simple cholecystectomy is treatment enough.
- 2.T1b, T2 or T3, no metastasesAHPBA consensus statement (HPB 2015); Soreide systematic review (Br J Surg 2019)
Referral to a hepatobiliary centre; interval CT or MRI and PET-CT; radical cholecystectomy (liver bed plus portal lymphadenectomy) at 4 to 8 weeks, with bile duct resection only for a positive cystic duct margin; port sites not routinely excised; adjuvant capecitabine after.
Systemic treatment as for advanced gallbladder cancer.
Generated from this cancer's standard of care, biomarkers and open problems. Take the group that matches where you are. To tick, add your own and print, open the one-page appointment sheet.
Newly diagnosed
- What is my exact diagnosis, stage, and grade, and which tests established them?Everything else follows from an accurate stage and subtype.
- Which biomarkers have been tested on my tumour (for example T category on the specimen, Cystic duct margin status, Whether the gallbladder was perforated or bile spilled at the first operation, Interval since cholecystectomy, Residual or distant disease on interval CT, MRI and PET-CT), and what were the results?These results decide eligibility for targeted therapy, immunotherapy, and trials.
- Which subtype is my cancer, and does that change the recommended treatment?Recognised subtypes for this cancer include Incidental gallbladder cancer, Tis or T1a, Incidental gallbladder cancer, T1b or deeper, Incidental gallbladder cancer with a positive cystic duct margin.
- Is germline (inherited) genetic testing recommended for me or my family?Inherited variants can change treatment and matter for relatives.
Tis or T1a with a clear cystic duct margin
- For my situation (tis or t1a with a clear cystic duct margin), which of the standard options do you recommend and why?Guideline options include: No further surgery; the simple cholecystectomy is treatment enough.
T1b, T2 or T3, no metastases
- For my situation (t1b, t2 or t3, no metastases), which of the standard options do you recommend and why?Guideline options include: Referral to a hepatobiliary centre; interval CT or MRI and PET-CT; radical cholecystectomy (liver bed plus portal lymphadenectomy) at 4 to 8 weeks, with bile duct resection only for a positive cystic duct margin; port sites not routinely excised; adjuvant capecitabine after.
- Am I a candidate for Capecitabine, and what side effects should I expect?Knowing the expected toxicities helps you plan work, family, and supportive care.
- How do the results of BILCAP apply to someone like me?Trial populations differ from individual patients; ask how closely you match.
Residual disease found on interval imaging or at re-operation
- For my situation (residual disease found on interval imaging or at re-operation), which of the standard options do you recommend and why?Guideline options include: Systemic treatment as for advanced gallbladder cancer.
- Am I a candidate for Gemcitabine + cisplatin, Durvalumab, Pembrolizumab, and what side effects should I expect?Knowing the expected toxicities helps you plan work, family, and supportive care.
Any stage
- Would a second opinion at a high-volume centre change anything, and can you help arrange it?Rare or high-stakes decisions benefit from a centre that treats many similar patients.
- What supportive care (symptom control, nutrition, exercise, mental health, financial help) is available from the start?Supportive care improves quality of life and helps patients complete treatment.
- I read that “Whether T1b tumours need re-resection: two 2024 to 2026 analyses disagree on disease-specific benefit”. How does that affect my plan?Open problems are where trials and second opinions matter most.
- I read that “How many UK patients with an incidental cancer reach a hepatobiliary centre is not published”. How does that affect my plan?Open problems are where trials and second opinions matter most.
Trials open now for this cancer in OnCo, largest phase first. Joining a trial is a decision like any other: ask what the comparison arm is, whether a placebo is used, and what happens if you leave. The cancer page searches ClinicalTrials.gov live for more.
- NEOGBPhase 3 · recruiting · NCT06712420Locally advanced resectable gallbladder cancer (including residual disease after cholecystectomy, bile spillage, piecemeal removal or regional node involvement on imaging): neoadjuvant chemotherapy then surgery versus upfront surgery
- OPT-IN (EA2197)Phase 2/3 · active · NCT04559139Incidental gallbladder cancer after cholecystectomy (T2 to T3): gemcitabine-cisplatin before and after re-resection vs re-resection then adjuvant chemotherapy
- POLCAGBPhase 2/3 · active · NCT02867865Locally advanced (T3 to T4) gallbladder cancer: neoadjuvant chemoradiotherapy vs neoadjuvant gemcitabine-based chemotherapy before attempted resection
Much of what helps in the first weeks is free if you know to ask: testing, helplines, rides and lodging, second opinions, trial travel.
- Incidental gallbladder cancer (found after cholecystectomy): the full pageIncidental gallbladder cancer is cancer the pathologist finds in a gallbladder removed for gallstones or inflammation, when nobody suspected it. It is the commonest way this cancer is found early enough to cure. Whether a second operation is needed depends on how deep the tumour went: none for the earliest layers, a radical operation at a specialist centre for T1b or deeper.
- One-page appointment sheetYour questions, the words you may hear, what to bring, and space for the answers. Print it.
- Treatment sequencingWhich treatment tends to follow which, line by line.
- NavigatorStandard of care for your stage, what you have tried, and trials near you.
- Port-site metastasis: Cancer growing in the small keyhole wounds of a laparoscopic operation, seeded when a gallbladder containing an unsuspected cancer was pulled out through them.
- Segment IVb and V liver resection (versus wedge resection): Two ways of removing the piece of liver the gallbladder sits on during a gallbladder cancer operation: a wedge of about two centimetres around the gallbladder bed, or the whole of the two anatomical liver segments (IVb and V) that touch it.
- Cystic duct margin: The cut end of the short duct that joined the gallbladder to the main bile duct, examined by the pathologist after a gallbladder is removed.
- Simple cholecystectomy: The standard operation to remove the gallbladder, almost always by keyhole surgery for gallstones.
- Radical (extended) cholecystectomy: The cancer operation for gallbladder cancer: the gallbladder (if still present) is removed together with a rim of the liver it sits against and the lymph nodes along the bile duct and liver blood vessels.
- Lymphadenectomy (lymph node dissection): Surgically removing the lymph nodes that drain a tumour, both to stage the cancer and to clear any spread.
Every term links to the glossary.